Key insights for the supplement industry on the medication revolutionizing health and wellness and suggestions for integrating the lactic acid metabolizer Veillonella into GLP-1 care.
Jonathan Scheiman, PhD, co-founder and CEO of FitBiomics
Advertisement
Jonathan Scheiman, PhD, is the co-founder and chief executive officer of FitBiomics, the NYC-based biotech company that is changing the way we understand and optimize our bodies through the gut.
Articles by Jonathan Scheiman, PhD, co-founder and CEO of FitBiomics
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
New food app leverages AI to help consumers understand ingredients right from grocery aisle
2
How Aged Garlic Extract is Changing Men's Vitality
3
Greenvit joins the collagen ingredient market
4
SAI Gold level status received by Layn Natural ingredients for monk fruit
5
